• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23378 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2007     HAYES, Inc. Ultrasound-enhanced transcutaneous drug delivery
1999     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Ultrasound-assisted lipoplasty
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Ultrasound versus computed tomography for children with suspected appendicitis: clinical evidence, cost-effectiveness, and guidelines
1997     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Ultrasound treatment - systematic review
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Ultrasound treatment - nonunion fractures
2014     HAYES, Inc. Ultrasound transient elastography for detecting hepatic fibrosis in patients with hepatitis C
2003     ECRI Ultrasound screening of normal-risk women for prevention of postterm pregnancy
2000     NIHR Health Technology Assessment programme Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women's views
2003     Adelaide Health Technology Assessment (AHTA) Ultrasound screening for hip dysplasia: a new screening programme for the early detection of hip dysplasia in neonates
2006     Medical Advisory Secretariat (MAS) Ultrasound screening for abdominal aortic aneurysm: an evidence-based analysis
2001     Centre for Clinical Effectiveness (CCE) Ultrasound or venogram for diagnosis of deep vein thrombosis (DVT)?
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Ultrasound of peripheral nerves
2004     Malaysian Health Technology Assessment Unit (MHTAU) Ultrasound in primary and antenatal care
2004     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Ultrasound in pregnancy - Evaluation of the routine ultrasound examinations according to the German Maternity Code
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Ultrasound imaging in the practice of anaesthesia
2012     HAYES, Inc. Ultrasound guidance to aid in the placement of peripherally inserted central catheter lines
2007     Adelaide Health Technology Assessment (AHTA) Ultrasound for assessment of risk of fracture
2000     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) Ultrasound diagnostic during pregnancy
2003     Institute for Clinical Systems Improvement (ICSI) Ultrasound cervical length for the prediction of preterm labor
2015     HAYES, Inc. Ultrasound bone growth stimulation
2003     HAYES, Inc. Ultrasound bone growth stimulation
2009     HAYES, Inc. Ultrasound bone growth stimulation
2000     ECRI Ultrasound bone densitometry for diagnosis of osteoporosis
2016     Health Quality Ontario (HQO) Ultrasound as an adjunct to mammography for breast cancer screening: OHTAC recommendation
2016     Health Quality Ontario (HQO) Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment
2002     Blue Cross Blue Shield Association (BCBS) Ultrasonography of peripheral sites for selecting patients for pharmacologic treatment for osteoporosis
1998     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Ultrasonography in primary health care. IPE-98/16 (Public report)
2014     Malaysian Health Technology Assessment (MaHTAS) Ultrasonic wound debridement device
2014     Agenzia nazionale per i servizi sanitari regionali (Agenas) Ultrasonic energy devices for surgery
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Ultrasonic cutting and coagulating devices
2015     Health Quality Ontario (HQO) Ultrafiltration in heart failure: a rapid review
2013     HAYES, Inc. Ultrafiltration in congestive heart failure
2008     VA Technology Assessment Program (VATAP) Ultrafiltration for heart failure
2010     VA Technology Assessment Program (VATAP) Ultrafiltration for decompensated heart failure
2006     NIHR Horizon Scanning Centre (NIHR HSC) Ultrafiltration for acute decompensated heart failure: horizon scanning technology briefing
2007     HAYES, Inc. Ultrafiltration for acute decompensated congestive heart failure
2003     Adelaide Health Technology Assessment (AHTA) Ultrafast magnetic resonance imaging (MRI) for patients undergoing conventional MRI
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ultra-low-dose Danazol (Optina; Vasaloc) for diabetic macular oedema
2023     Health Information and Quality Authority (HIQA) Ultra-hypofractionated adjuvant radiotherapy for breast cancer: evidence synthesis to support a generic justification decision
2015     Adelaide Health Technology Assessment (AHTA) Ultra-filtration for patients with decompensated heart failure
2022     NIHR Health Technology Assessment programme Ulipristal acetate versus conventional management of heavy menstrual bleeding (HMB; including uterine fibroids): a randomised controlled trial and exploration of mechanism of action (UCON trial)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Ulipristal Acetate (Fibristal - Actavis Specialty Pharmaceuticals Co.) indication: uterine fibroids
2016     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ulipristal acetate (Esmya®)
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ulipristal acetate (Esmya®)
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ularitide for acute decompensated heart failure – first line
2020     NIHR Health Services and Delivery Research programme UK Study of tendon Achilles Rehabilitation multicentre randomised clinical trial (UK STAR)
2018     NIHR Health Technology Assessment programme UK Lung Cancer Screening Trial (UKLS) - Feasibility study and protocol development
1995     NIHR Health Technology Assessment programme UK home parenteral nutrition register
2016     NIHR Health Technology Assessment programme UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
2016     NIHR Health Technology Assessment programme UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
2015     NIHR Health Technology Assessment programme UK DRAFFT: a randomised controlled trial of percutaneous fixation with Kirschner wires versus volar locking-plate fixation in the treatment of adult patients with a dorsally displaced fracture of the distal radius
2021     NIHR Health Technology Assessment programme UK Cohort study to Investigate the prevention of Parastomal Hernia (CIPHER)
2010     HAYES, Inc. UGT1A1 Sequence Variant Testing for Predicting Response to Irinotecan Therapy in Colorectal Cancer
2022     National Institute for Health and Care Excellence (NICE) TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal). NICE technology appraisal guidance 790
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors, immune checkpoint inhibitors and everolimus for treating advanced renal cell cancer
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors for treating MET mutation-positive metastatic non-small-cell lung cancer
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors for treating ALK mutation-positive advanced non-small-cell lung cancer
2014     Malaysian Health Technology Assessment (MaHTAS) Typhoid carrier test (Typhidot-C)
2012     NIHR Health Technology Assessment programme Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antisepticimpregnated urethral catheters (the CATHETER trial)
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Type 2 diabetes. Health technology assessment of screening, diagnosis and treatment
2004     National Institute for Clinical Excellence (NICE) Type 2 diabetes: Prevention and management of foot problems
2004     National Institute for Clinical Excellence (NICE) Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults
2017     Agency for Healthcare Research and Quality (AHRQ) Tympanostomy tubes in children with otitis media
2002     HAYES, Inc. Tympanoplasty for recurrent and chronic otitis media
2006     University HealthSystem Consortium (UHC) Tygacil
2022     Medical Services Advisory Committee (MSAC) Two testing options for determining eligibility for access to Pharmaceutical Benefits Schedule-subsidised aducanumab in patients with early stage Alzheimer disease
2020     NIHR Health Technology Assessment programme Two speeds of increasing milk feeds for very preterm or very low-birthweight infants: the SIFT RCT
2018     NIHR Health Technology Assessment programme Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study
2012     Medical Advisory Secretariat (MAS) Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis
2014     Health Quality Ontario (HQO) Turning for ulcer reduction (TURN) study: an economic analysis
2014     Health Quality Ontario (HQO) Turning for the prevention and management of pressure ulcers: OHTAC Recommendation
2022     National Institute for Health and Care Excellence (NICE) Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis. NICE interventional procedures guidance 746
2011     Penn Medicine Center for Evidence-based Practice (CEP) Tunneled vs. non-tunneled catheters for acute hemodialysis
2003     The Swedish Council on Health Technology Assessment (SBU) TUNA - Transurethral needle ablation for BPH - early assessment briefs (Alert)
2023     Scottish Health Technologies Group (SHTG) Tumour profiling tests to guide chemotherapy decisions in early breast cancer
2024     National Institute for Health and Care Excellence (NICE) Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer. NICE diagnostics guidance 58
2019     NIHR Health Technology Assessment programme Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis
2016     NIHR Health Technology Assessment programme Tumour necrosis factor- inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation
2002     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Tumor-necrosis-factor alpha-antagonists in the treatment of rheumatoid arthritis - Medical efficacy
2005     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Tumor-necrosis-factor alpha-antagonists in the treatment of rheumatoid arthritis - Economic efficiency
2003     The Swedish Council on Health Technology Assessment (SBU) Tumor vaccination- early assessment briefs (Alert)
2024     Swiss Federal Office of Public Health (FOPH) Tumor treating fields (TTFields) therapy for patients with glioblastoma multiforme
2011     HAYES, Inc. Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS; Familial Hibernian Fever)
2002     Health Technology Advisory Committee (HTAC) Tumescent liposuction
2001     HAYES, Inc. Tumescent liposuction
2022     National Institute for Health and Care Excellence (NICE) Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies. NICE technology appraisal guidance 786
2010     HAYES, Inc. Tuberous Sclerosis Complex (TSC; Bourneville Disease)
2006     National Institute for Health and Care Excellence (NICE) Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tuberculosis testing for correctional staff: diagnostic accuracy and guidelines
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) TruScan
2008     NIHR Horizon Scanning Centre (NIHR HSC) TroVax (MVA-5T4) for locally advanced or metastatic renal cell carcinoma – with first line therapy
1997     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Troglitazone for Type II diabetes
2011     HAYES, Inc. Trofile™ HIV tropism assay
2016     NIHR Horizon Scanning Centre (NIHR HSC) Triptorelin (Decapeptyl SR) for premenopausal women with early endocrine responsive breast cancer
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for migraine headaches: a review of clinical evidence on safety
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for acute migraine: comparative clinical effectiveness and cost-effectiveness
2000     British Columbia Office of Health Technology Assessment (BCOHTA) Triple-marker screening in British Columbia: current practice, future options
2019     Penn Medicine Center for Evidence-based Practice (CEP) Triple-lumen peripherally-inserted central catheters
2018     NIHR Health Technology Assessment programme Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for moderate-to-severe chronic obstructive pulmonary disease